James Mandell, Director at bluebird bio, Inc. (BLUE), sold 5,000 shares at $70.10 ($351K) on 2017-01-27, disclosed to the SEC on 2017-01-31.
Open-market sale of $350k BLUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BLUE | SELL | 2017-02-17 | $84K | — | Filing → |
| BLUE | SELL | 2017-02-16 | $952K | — | Filing → |
| BLUE | SELL | 2017-02-02 | $600K | — | Filing → |